drugset / Trial / NCT05276531

Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support

NCT05276531

Completed 146 enrolled Bezmialem Vakif University
RandomizedParallel-groupOpen-labelSupportive care

Summary

The invesigators aimed to seperate the patients,which is going to be applied IUI, to two different groups as prospective randomized controlled ;assess the efficacy of the two different way pressurised progesterone by appling intravaginal progesterone to the first group; subcutaneous to the second group.

Timeline

Start
2022-04-01
Primary completion
2022-06-01
Completion
2022-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 25 mg Subcutaneous
Subject Progesterone Other / unclassified 100 mg Subcutaneous

Indications

No indication recorded.